Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hemoglobin ; 39(1): 36-41, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25395219

RESUMO

Abstract ß-Thalassemia (ß-thal) is a genetic disorder, representing a major health problem in Algeria. It is associated with altered lipid levels and a state of oxidative stress that can lead to cardiac complications and premature death. We examined the plasma lipid profile and redox status of 46 patients with ß-thal major (ß-TM) and ß-thal intermedia (ß-TI) compared to 36 healthy subjects. Plasma lipids including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were investigated. Oxidative status was evaluated by measuring malondialdehyde (MDA), reduced glutathione (GSH) and catalase (CAT) activity. The potential relationships between these parameters and the hemoglobin (Hb) blood concentrations, serum ferritin, duration and frequency of transfusion, splenectomy as well as age, were examined. Our data indicated that the study patients were under increased state of oxidative stress associated with hypertriglyceridemia, and hypocholesterolemia. The CAT activity was negatively correlated with Hb concentration and LDL-C/TG ratio and positively with years of transfusion. The elevated TC/HDL-C ratio particularly in ß-TM patients who were younger, correlated positively with ferritinemia and triglyceride levels and suggested an increased coronary risk. This heightened risk state should lead to the inclusion of this index (TC/HDL-C) in clinical management, particularly in splenectomized patients.


Assuntos
Metabolismo dos Lipídeos , Lipídeos/sangue , Estresse Oxidativo , Talassemia beta/sangue , Talassemia beta/metabolismo , Adolescente , Adulto , Catalase/sangue , Catalase/metabolismo , Feminino , Glutationa/sangue , Glutationa/metabolismo , Humanos , Masculino , Malondialdeído/sangue , Malondialdeído/metabolismo , Oxirredução , Adulto Jovem , Talassemia beta/complicações
2.
Am J Physiol Heart Circ Physiol ; 302(3): H665-74, 2012 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-22101527

RESUMO

The present study was designed to characterize the mitochondrial dysfunction induced by catecholamines and to investigate whether curcumin, a natural antioxidant, induces cardioprotective effects against catecholamine-induced cardiotoxicity by preserving mitochondrial function. Because mitochondria play a central role in ischemia and oxidative stress, we hypothesized that mitochondrial dysfunction is involved in catecholamine toxicity and in the potential protective effects of curcumin. Male Wistar rats received subcutaneous injection of 150 mg·kg(-1)·day(-1) isoprenaline (ISO) for two consecutive days with or without pretreatment with 60 mg·kg(-1)·day(-1) curcumin. Twenty four hours after, cardiac tissues were examined for apoptosis and oxidative stress. Expression of proteins involved in mitochondrial biogenesis and function were measured by real-time RT-PCR. Isolated mitochondria and permeabilized cardiac fibers were used for swelling and mitochondrial function experiments, respectively. Mitochondrial morphology and permeability transition pore (mPTP) opening were assessed by fluorescence in isolated cardiomyocytes. ISO treatment induced cell damage, oxidative stress, and apoptosis that were prevented by curcumin. Moreover, mitochondria seem to play an important role in these effects as respiration and mitochondrial swelling were increased following ISO treatment, these effects being again prevented by curcumin. Importantly, curcumin completely prevented the ISO-induced increase in mPTP calcium susceptibility in isolated cardiomyocytes without affecting mitochondrial biogenesis and mitochondrial network dynamic. The results unravel the importance of mitochondrial dysfunction in isoprenaline-induced cardiotoxicity as well as a new cardioprotective effect of curcumin through prevention of mitochondrial damage and mPTP opening.


Assuntos
Cardiomegalia/tratamento farmacológico , Cardiotônicos/farmacologia , Curcumina/farmacologia , Isoproterenol/toxicidade , Doenças Mitocondriais/tratamento farmacológico , Proteínas de Transporte da Membrana Mitocondrial/metabolismo , Agonistas Adrenérgicos beta/toxicidade , Animais , Apoptose/efeitos dos fármacos , Cardiomegalia/induzido quimicamente , Cardiomegalia/metabolismo , Catecolaminas/metabolismo , Modelos Animais de Doenças , Interações Medicamentosas , Inibidores Enzimáticos/farmacologia , Masculino , Doenças Mitocondriais/induzido quimicamente , Doenças Mitocondriais/metabolismo , Poro de Transição de Permeabilidade Mitocondrial , Miocardite/induzido quimicamente , Miocardite/tratamento farmacológico , Miocardite/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...